New therapies for postural hypotension.
New therapies for postural hypotension.
复制标题
体位性低血压的新疗法。
DOI:
10.1161/hypertensionaha.111.187278
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
Milic,Milos
中科院分区:
文献类型:
--
作者:
Ziegler,MichaelG;Milic,Milos
Patients with deterioration of the autonomic nervous sys-tem can have unexpected or even paradoxical reactions to common cardiovascular drugs. For example, patients with severe neuropathy of the peripheral autonomic system can have a pressor response to phenylephrine eye drops and a paradoxical increase in blood pressure (BP) from the antihypertensive clonidine. 1 Currently, the only approved therapy for postural hypotension in the United States is midodrine, an α1 agonist. The most common therapy is fludrocortisone, which causes sodium retention and sensitizes blood vessels to pressors. Both of these therapies raise BP irrespective of posture, so they can lead to recumbent hypertension. The pressor effect of midodrine is short lived, and it is customarily withheld in the evening. The pressor effect of fludrocortisone is long lived. Even combined therapy often leaves patients with symptomatic postural lightheadedness. Arterial BP is controlled by negative feedback loops, especially the baroreflex (Figure). Stretch of the baroreceptor fires afferent nerves and initiates autonomic cardiovascular reflexes. The baroreflex is impaired by aging and hypertension as increasingly rigid blood vessels stretch poorly. When the baroreceptor is no longer stretched by high BP, it fails to input nerve signals to the brain stem, thus failing to either activate vagal cardiodepressor nerves or to withdraw outflow to sympathetic vasoconstrictor fibers. Patients with stiff baroreceptors from uncommon causes, such as neck radiotherapy, or common causes, such as atherosclerosis, have wide BP swings with exaggerated pressor responses to stress. Some will have symptomatic hypotension after a high carbohydrate meal. The wide BP swings characteristic of aging hypertensives are a manifestation of failure of the baroreceptor to activate the baroreflex loop to buffer BP through the autonomic nervous system. The baroreflex loop is also interrupted by diseases of the brain stem, such as multisystem atrophy, or by diseases of peripheral autonomic nerves. Both causes of autonomic failure lead to postural symptoms from low BP. Drugs that alter BP usually affect the baroreflex set point or sensitivity. For example yohimbine increases heart rate by decreasing the cardiovagal baroreflex. 2 Inhibitors of either the norepinephrine (NE) reuptake transporter (NET) or monoamine oxidase might be expected to raise BP by increasing intrasynaptic NE. They instead lower the BP of standing persons. This is because prolonged NE stimulation of α2 receptors inhibits sympathetic nervous outflow. The α2 receptors are stimulated by NE and clonidine and are blocked by yohimbine. Yohimbine increases plasma NE and BP in normal subjects and has a greater pressor effect in some patients with peripheral autonomic neuropathy. Yohimbine also interacts with several tricyclic antidepressants that block NET. The combination of clomipramine, 3 nortriptyline, 4 or desipramine5 with yohimbine can have a marked pressor effect. Yohimbine also counteracts the postural hypotension induced by tricyclic antidepressants. 6 The therapeutic pressor effect of an α2 blocker combined with a NET inhibitor had not been studied in patients with postural hypotension because of autonomic disease before the report of Okamoto et al. 7Neuropathy of the peripheral autonomic nerves can lead to troublesome postural hypotension and may be the consequence of common illnesses, such as diabetes mellitus or parkinsonism. Peripheral neuropathy depletes stores of neuronal NE. Maximizing release of NE through precursors, such as droxidopa, or minimizing inhibition of NE release by inhibiting adenosine A1 receptors …